Safety assessment of a single and a repeated dose administration of the inactivated vaccine ERAVAC® in dwarf pet rabbits
Safety assessment of a single and a repeated dose administration of the inactivated vaccine ERAVAC® in dwarf pet rabbits
The main objective of this study was to evaluate the safety and serological response of ERAVAC® (HIPRA, Spain), an inactivated vaccine for preventing the new variant of rabbit haemorrhagic disease virus (RHDV-2), when administered into dwarf pet rabbits.
The contents of this page are country specific and aimed specifically at prescribing veterinarians.
This product is not available in {{ preferredCountry.title }}.
You will be redirected to our global site. Click on continue to visit our global site (available in English).
Confirm that you are a veterinary professional:
- I am a veterinarian (otherwise please contact a veterinary professional)
Select your country:
- Global (available in English)
- {{country.title}}